← FDA DRUG APPROVALS

FDA ANDA · ANDA089773

MINITRAN

Sponsor: BAUSCH

APPLICATION
ANDA089773
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-30
LATEST ACTION
2001-08-13
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

MINITRANDiscontinued
NITROGLYCERIN 0.4MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

2001-08-13Manufacturing (CMC) · Supplement 28AP
2000-01-18Labeling · Supplement 26AP
1999-06-11Manufacturing (CMC) · Supplement 25AP
1998-06-16Manufacturing (CMC) · Supplement 24AP
1996-08-30Labeling · Supplement 22AP
1996-08-30OriginalAP
1996-08-30Manufacturing (CMC) · Supplement 21AP
1995-12-21Manufacturing (CMC) · Supplement 23AP
1994-09-23Manufacturing (CMC) · Supplement 20AP
1993-09-24Manufacturing (CMC) · Supplement 17AP
1993-02-01Manufacturing (CMC) · Supplement 13AP
1992-09-11Bioequivalence · Supplement 12AP
1992-03-30Manufacturing (CMC) · Supplement 9AP
1992-02-25Bioequivalence · Supplement 11AP
1991-04-22Manufacturing (CMC) · Supplement 4AP
1991-04-22Manufacturing (CMC) · Supplement 3AP
1988-11-28Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →